Skip to main content
Clinical Trials/NCT01019213
NCT01019213
Completed
Phase 4

Acute and Chronic Effect of His-pacing in Consecutive Patients With AV-block

Aarhus University Hospital Skejby1 site in 1 country40 target enrollmentSeptember 2007

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Atrioventricular Block
Sponsor
Aarhus University Hospital Skejby
Enrollment
40
Locations
1
Primary Endpoint
Left ventricular ejection fraction (LVEF)
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

Conventional right ventricular (RV) apical pacing may result in asynchronous ventricular contraction with delayed left ventricular activation, interventricular motion abnormalities, and worsening of left ventricular ejection fraction. His pacing is preserving a synchronous contraction and may prevent a decrease in left ventricular ejection fraction.

Hypothesis: His-pacing preserves left ventricular function and is a feasable alternative compared to RV septal septal pacing in patients with AV-block.

Detailed Description

Conventional right ventricular apical pacing may result in asynchronous ventricular contraction with delayed left ventricular activation, interventricular motion abnormalities, and worsening of left ventricular ejection fraction. His pacing is preserving a synchronous contraction and may prevent a decrease in left ventricular ejection fraction. The aims of our crossover, double-blinded, randomized study is to evaluate the feasibility and long-term safety of permanent His pacing and to compare the effects on left ventricular ejection fraction of permanent His pacing with those of conventional right septal stimulation after 12 months treatment in patients with 2nd or 3rd degree AV-block.

Registry
clinicaltrials.gov
Start Date
September 2007
End Date
September 2011
Last Updated
13 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Aarhus University Hospital Skejby
Responsible Party
Principal Investigator
Principal Investigator

Mads Brix Kronborg

Dr.

Aarhus University Hospital Skejby

Eligibility Criteria

Inclusion Criteria

  • 2nd or 3rd degree Av block

Exclusion Criteria

  • QRS \> or = 120 ms
  • Indication for cardiac resynchronization therapy (CRT) or implantable cardioverter defibrillator (ICD)
  • chronic atrial fibrillation
  • Expected heart surgery \< 2 years
  • Expected survival \> 2 years
  • Patients that have been His ablated
  • Serious comorbidity

Outcomes

Primary Outcomes

Left ventricular ejection fraction (LVEF)

Time Frame: 12 months

Secondary Outcomes

  • Quality of life(12 months)
  • Synchrony by echocardiography(12 months)
  • New York Heart Association (NYHA) class(12)
  • 6-minute hall walk test(12)

Study Sites (1)

Loading locations...

Similar Trials